| n = 107 |
---|---|
Age, years (range) | 63 (29–77) |
Sex | |
 Male | 60 (56%) |
 Female | 47 (44%) |
Eastern Clinical Oncology Group (ECOG) paformance status | |
 0 | 93 (87%) |
 1 | 14 (13%) |
Main location of the tumor | |
 Rectosigmoid | 5 (5%) |
 Upper rectum | 54 (50%) |
 Lower rectum | 48 (45%) |
Surgical approach | |
 Laparoscopic | 77 (72%) |
 Open | 30 (28%) |
Surgical procedure | |
 HAR | 10 (9%) |
 LAR | 79 (74%) |
 ISR | 4 (4%) |
 Hartmann’s procedure | 2 (2%) |
 APR | 12 (11%) |
 Lateral lymph node dissection by the main location of the tumor | 19 (18%) |
 Upper rectum | 3 |
 Lower rectum | 16 |
 Operation time, minutes (range) | 311 (122–914) |
 Intraopelative bleeding, ml (range) | 45 (0–2100) |
 Stoma creation | 47 (44%) |
 Postoperative complications | 18 (17%) |
Histology | |
 pap/tub1/tub2 | 1/33/71 |
 por1/por2/muc/sig | 1/1/0/0 |
Pathological T category | |
 T1 | 7 (7%) |
 T2 | 19 (18%) |
 T3 | 66 (62%) |
 T4a | 12 (11%) |
 T4b | 3 (3%) |
Pathological N category | |
 N0 | 8 (8%) |
 N1a | 24 (22%) |
 N1b | 29 (27%) |
 N2a | 21 (20%) |
 N2b | 25 (23%) |
Pathological stage | |
 IIA | 5 (5%) |
 IIB | 3 (3%) |
 IIIA | 17 (16%) |
 IIIB | 57 (53%) |
 IIIC | 25 (23%) |